News

Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
Lantern Pharma Inc. (Nasdaq: LTRN), an artificial intelligence company developing targeted and transformative cancer ...
New method allows live-cell protein tagging without interfering with function
University of Pennsylvania researchers have developed a powerful new investigative tool to reveal how proteins work inside ...